Short Interest in Straumann Holding AG (OTCMKTS:SAUHY) Drops By 93.9%

Straumann Holding AG (OTCMKTS:SAUHY) saw a large decline in short interest during the month of June. As of June 15th, there was short interest totaling 1,880 shares, a decline of 93.9% from the May 31st total of 30,585 shares. Currently, 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 124,355 shares, the short-interest ratio is currently 0.0 days.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on SAUHY shares. Citigroup reaffirmed a “sell” rating on shares of Straumann in a research report on Thursday, April 23rd. Morgan Stanley restated an “underweight” rating on shares of Straumann in a research note on Tuesday, April 14th. Finally, Barclays reaffirmed an “overweight” rating on shares of Straumann in a report on Thursday, June 18th. Two analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Straumann currently has a consensus rating of “Hold”.

Straumann Trading Up 2.6%

OTCMKTS SAUHY traded up $0.33 during trading on Thursday, reaching $13.19. The company’s stock had a trading volume of 34,501 shares, compared to its average volume of 57,254. Straumann has a twelve month low of $9.44 and a twelve month high of $14.11. The business’s fifty day moving average price is $11.53 and its 200-day moving average price is $11.55.

About Straumann

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.